# Liquidia Sets 2028 PH-ILD Goal, 2029 L606 NDA Submission Target

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54305
Published: 2026-11-11T18:12:57.000Z
Updated: 2026-11-11T18:12:57.000Z
Section: Business

> Liquidia Corporation plans to complete PH-ILD enrollment in 2028 and has a 2029 target for an L606 new drug application submission.

Liquidia Corporation is aiming to finish PH-ILD enrollment in 2028 and has set a 2029 target for an L606 new drug application submission, outlining two development milestones across consecutive years.

The 2029 submission target falls in the calendar year after the enrollment milestone.